α
AlphaScala
StocksSignalsNEWAlpha ScoreBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsAlpha ScoreHedge Funds 13FInsider BuysAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

For AI AgentsAlphaScala is agent-ready —skill.md·llms.txt
© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala — Built with data, not hype.
All Stocks/Healthcare/ELV

Elevance Health Inc.

ELVNYSE
HealthcareHealthcare Plans Website
Alpha Score
48
Weak
Signal SnapshotMarket signals →
Alpha Score
48 · Weak
Alpha Score of 48 reflects weak overall profile with strong momentum, weak value, weak quality. Based o...
Updated May 3
Insider Activity
-$49K net
1 buys and 2 sells in the 90-day rollup.
Form 4 · Mar 12
13F Holder
Citadel
$827.53M reported position; latest action: new.
Ken Griffin
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about ELVAI research agent
Alpha Score BreakdownHow it works →

Alpha Score of 48 reflects weak overall profile with strong momentum, weak value, weak quality. Based on 3 of 4 signals — score is capped at 90 until remaining data ingests.

Momentum
71
Moderate
Value
39
Weak
Quality
45
Weak
Sentiment
—
no data
Key StatisticsUpdated Apr 15
P/E Ratio
32.34
Forward P/E
—
PEG Ratio
—
EPS (TTM)
9.69
Dividend Yield
2.20%
Beta
0.51
Revenue (TTM)
—
Net Margin
2.84%
ROE
13.01%
Debt / Equity
0.73
52W High
$452.69
52W Low
$274.66
Daily CommentaryAI-written, data-grounded

Elevance Health Faces Margin Headwinds Amidst Moderate Valuation and Growth Metrics

Apr 15, 2026

Elevance Health (ELV) closed today reflecting a complex fundamental picture as the stock trades within its 52-week range of $274.66 to $452.69. The company currently commands a P/E ratio of 32.34, which sits against a backdrop of divergent growth indicators. While revenue growth remains robust at 12.6% year-over-year, earnings per share growth has contracted by 2.0%, resulting in an EPS of 9.69. The firm maintains a thin net margin of 2.8%, highlighting the operational pressures currently influencing the healthcare sector. The broader Alpha Score of 37.2 reflects these mixed signals, with sub-scores of 40.2 for momentum, 39.2 for value, and 44.7 for quality. These metrics suggest that while the company maintains a stable quality profile, the lack of positive sentiment and the decline in earnings growth are weighing on overall market performance. Investors are currently balancing the double-digit revenue expansion against the compression in bottom-line profitability. Market participants should monitor upcoming quarterly earnings reports to determine if margin expansion can align with current revenue growth trajectories.

Insider ActivitySEC Form 4 filings
Buys (90d)
1
Sells (90d)
2
Net $ (90d)
$-49K
Unique insiders
3
DateInsiderRoleTypeSharesValue
Mar 12, 26Schulman Amy WDirectorSELL26$7K
Mar 6, 26Kendrick Charles Morgan JrEVP & President, CommercialSELL3.2K$911K
Mar 5, 26Collis Steven HDirectorBUY3.0K$870K
See cluster-buy signals across all tickers →
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Citadel
Ken Griffin
2.36M$827.53MNEW
D.E. Shaw
David Shaw
563K$197.46MNEW
Point72
Steve Cohen
57K$19.91MNEW
Explore all tracked funds →
About Elevance Health Inc.

Elevance Health, Inc. is a leading health company that operates through key segments including Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment provides a comprehensive suite of commercial, Medicare, and Medicaid health plans, along with managed care options like preferred provider organizations, serving employers, individuals, families, and communities across multiple states via affiliates such as Anthem Blue Cross and Blue Shield and Wellpoint. CarelonRx delivers pharmacy services to both affiliated health plan members and external customers. Carelon Services integrates physical, behavioral, pharmacy, and social care to support whole health affordably through risk-based solutions, clinical expertise, and partnerships with health plans, government agencies, and providers. This holistic approach addresses physical, behavioral, and social needs, enhanced by digital tools and data insights for better outcomes, affordability, equity, and access. Founded in 1944 and headquartered in Indianapolis, Indiana, Elevance Health plays a pivotal role in the U.S. healthcare market by simplifying care delivery and advancing integrated health solutions for diverse populations.

CEO
Ms. Gail Koziara Boudreaux
Employees
96,129
Quick Facts
ExchangeNYSE
SectorHealthcare
IndustryHealthcare Plans
Market Cap—
Avg Volume1.60M
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when ELV reports next.

Get earnings alerts →